CY1124192T1 - Συσκευες για την in vivo χορηγηση φαρμακων - Google Patents
Συσκευες για την in vivo χορηγηση φαρμακωνInfo
- Publication number
- CY1124192T1 CY1124192T1 CY20211100479T CY211100479T CY1124192T1 CY 1124192 T1 CY1124192 T1 CY 1124192T1 CY 20211100479 T CY20211100479 T CY 20211100479T CY 211100479 T CY211100479 T CY 211100479T CY 1124192 T1 CY1124192 T1 CY 1124192T1
- Authority
- CY
- Cyprus
- Prior art keywords
- drug
- reservoir
- drug delivery
- devices
- methods
- Prior art date
Links
- 238000012377 drug delivery Methods 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 206010020853 Hypertonic bladder Diseases 0.000 abstract 1
- 208000009722 Overactive Urinary Bladder Diseases 0.000 abstract 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 abstract 1
- 206010046543 Urinary incontinence Diseases 0.000 abstract 1
- 230000001272 neurogenic effect Effects 0.000 abstract 1
- 208000020629 overactive bladder Diseases 0.000 abstract 1
- 208000020431 spinal cord injury Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0017—Catheters; Hollow probes specially adapted for long-term hygiene care, e.g. urethral or indwelling catheters to prevent infections
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0069—Devices for implanting pellets, e.g. markers or solid medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A61M2025/0057—Catheters delivering medicament other than through a conventional lumen, e.g. porous walls or hydrogel coatings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/04—General characteristics of the apparatus implanted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2210/00—Anatomical parts of the body
- A61M2210/10—Trunk
- A61M2210/1078—Urinary tract
- A61M2210/1085—Bladder
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762453333P | 2017-02-01 | 2017-02-01 | |
| US201762480744P | 2017-04-03 | 2017-04-03 | |
| PCT/US2018/016463 WO2018144738A1 (en) | 2017-02-01 | 2018-02-01 | In vivo drug delivery devices and methods for drug delivery |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1124192T1 true CY1124192T1 (el) | 2022-05-27 |
Family
ID=61231348
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20211100479T CY1124192T1 (el) | 2017-02-01 | 2021-06-01 | Συσκευες για την in vivo χορηγηση φαρμακων |
Country Status (23)
| Country | Link |
|---|---|
| US (3) | US11020575B2 (enExample) |
| EP (1) | EP3432970B1 (enExample) |
| JP (1) | JP7366748B2 (enExample) |
| KR (1) | KR102564771B1 (enExample) |
| CN (1) | CN110418658A (enExample) |
| AU (2) | AU2018217094B2 (enExample) |
| CA (1) | CA3052148A1 (enExample) |
| CY (1) | CY1124192T1 (enExample) |
| DK (1) | DK3432970T3 (enExample) |
| ES (1) | ES2873084T3 (enExample) |
| HR (1) | HRP20210571T1 (enExample) |
| HU (1) | HUE054587T2 (enExample) |
| IL (1) | IL268385B (enExample) |
| LT (1) | LT3432970T (enExample) |
| MX (2) | MX2019009080A (enExample) |
| PL (1) | PL3432970T3 (enExample) |
| PT (1) | PT3432970T (enExample) |
| RS (1) | RS62459B1 (enExample) |
| RU (1) | RU2759868C2 (enExample) |
| SG (1) | SG11201907033SA (enExample) |
| SI (1) | SI3432970T1 (enExample) |
| SM (1) | SMT202100310T1 (enExample) |
| WO (1) | WO2018144738A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019234675A1 (en) * | 2018-03-13 | 2020-10-01 | Vertex Pharmaceuticals Incorporated | Implantation devices, system, and methods |
| CA3107461A1 (en) * | 2018-08-01 | 2020-02-06 | Taris Biomedical Llc | Methods of treating overactive bladder using trospium |
| CN109765118B (zh) * | 2018-12-22 | 2021-09-17 | 临沂协润工贸有限公司 | 一种纺织品韧性测试仪 |
| KR20220146361A (ko) * | 2021-04-23 | 2022-11-01 | 김승범 | 과민성 방광 치료 장치 |
| CN113274624B (zh) * | 2021-07-06 | 2023-05-12 | 中南大学湘雅医院 | 一种可视化尿道扩张术后治疗仪 |
| MX2024007818A (es) | 2021-12-21 | 2024-09-06 | Taris Biomedical Llc | Catéter de colocación urinario para dispositivos intravesicales. |
| CN119072311A (zh) | 2022-02-18 | 2024-12-03 | 塔里斯生物医药公司 | 用于膀胱内施用的厄达替尼制剂和渗透系统 |
| WO2024092159A1 (en) | 2022-10-28 | 2024-05-02 | Taris Biomedical Llc | Methods of treating bladder cancer with gemcitabine |
| WO2024173716A1 (en) | 2023-02-17 | 2024-08-22 | Taris Biomedical Llc | Erdafitinib for intravesical administration for use in the treatment of bladder cancer |
| WO2024215682A1 (en) | 2023-04-10 | 2024-10-17 | Taris Biomedical Llc | Gemcitabine for use in methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guerin therapy |
| WO2025076007A1 (en) | 2023-10-02 | 2025-04-10 | Taris Biomedical Llc | Methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guérin therapy |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4210139A (en) | 1979-01-17 | 1980-07-01 | Alza Corporation | Osmotic device with compartment for governing concentration of agent dispensed from device |
| US4657536A (en) | 1979-04-13 | 1987-04-14 | Regents Of The University Of Minnesota | Check valve catheter |
| US5340590A (en) | 1987-06-25 | 1994-08-23 | Alza Corporation | Delivery system with bilayer osmotic engine |
| US5456679A (en) | 1992-02-18 | 1995-10-10 | Alza Corporation | Delivery devices with pulsatile effect |
| US5221278A (en) | 1992-03-12 | 1993-06-22 | Alza Corporation | Osmotically driven delivery device with expandable orifice for pulsatile delivery effect |
| PT621032E (pt) | 1993-04-23 | 2001-01-31 | Novartis Ag | Dispositivo de distribuicao de libertacao controlada de farmaco |
| ZA981610B (en) * | 1997-03-24 | 1999-08-26 | Alza Corp | Self adjustable exit port. |
| US6436091B1 (en) * | 1999-11-16 | 2002-08-20 | Microsolutions, Inc. | Methods and implantable devices and systems for long term delivery of a pharmaceutical agent |
| US8740973B2 (en) * | 2001-10-26 | 2014-06-03 | Icon Medical Corp. | Polymer biodegradable medical device |
| EP1613389B8 (en) | 2003-03-31 | 2008-05-07 | Intarcia Therapeutics, Inc. | Osmotic pump with means for dissipating internal pressure |
| BRPI0414941A (pt) | 2003-09-30 | 2006-11-07 | Alza Corp | dispositivo de distribuição de agente ativo acionado osmoticamente proporcionando um perfil de liberação ascendente |
| US7455688B2 (en) * | 2004-11-12 | 2008-11-25 | Con Interventional Systems, Inc. | Ostial stent |
| DK1933810T3 (da) | 2005-08-11 | 2013-01-28 | Childrens Medical Center | Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde |
| US20100003297A1 (en) * | 2005-08-11 | 2010-01-07 | Massachusetts Institute Of Technology | Implantable Drug Delivery Device and Methods of Treating Male Genitourinary and Surrounding Tissues |
| MX2009001114A (es) | 2006-08-09 | 2009-02-10 | Intarcia Therapeutics Inc | Sistemas de suministro osmotico y ensambles de piston. |
| DK2231254T3 (da) * | 2007-12-11 | 2014-07-21 | Massachusetts Inst Technology | Implanterbar lægemiddelafgivelsesindretning |
| US8343516B2 (en) * | 2009-06-26 | 2013-01-01 | Taris Biomedical, Inc. | Solid drug tablets for implantable drug delivery devices |
| US9017312B2 (en) * | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| US8167836B2 (en) | 2009-12-08 | 2012-05-01 | Taris Biomedical, Inc. | Tissue expander configured for drug delivery |
| US8679094B2 (en) | 2009-12-17 | 2014-03-25 | Taris Biomedical, Inc. | Implantable device with intravesical tolerability and methods of treatment |
| US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
| PT2600800T (pt) * | 2010-08-05 | 2020-11-05 | Taris Biomedical Llc | Dispositivo de administração de drogas por stent ureteral, kit e método |
| US8690840B2 (en) * | 2010-10-06 | 2014-04-08 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
| US9114111B2 (en) | 2011-01-10 | 2015-08-25 | Allergan, Inc. | Methods for sustained treatment of bladder pain and irritative voiding |
| WO2012106714A1 (en) | 2011-02-04 | 2012-08-09 | Taris Biomedical, Inc. | Implantable device for controlled release of low solubility drug |
| CA2872092C (en) * | 2012-04-30 | 2021-02-16 | Taris Biomedical, Inc. | Methods for treatment of pelvic pain and/or comorbid conditions |
| US20150202161A1 (en) * | 2012-08-20 | 2015-07-23 | O-Ray Pharma, Inc. | Process for manufacturing drug delivery formulations |
| MX379066B (es) | 2012-09-18 | 2025-03-04 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior. |
| JP2016508842A (ja) * | 2013-03-05 | 2016-03-24 | タリス バイオメディカル エルエルシー | 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法 |
| US9533101B2 (en) | 2013-03-14 | 2017-01-03 | Leonard Allen Massey, JR. | Multi-cycle and auto-disable syringe and method of use thereof |
| SG11201507294WA (en) * | 2013-03-15 | 2015-10-29 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| EP2968120A1 (en) | 2013-03-15 | 2016-01-20 | TARIS Biomedical LLC | Drug delivery devices and methods for drug delivery |
| WO2015026813A1 (en) * | 2013-08-19 | 2015-02-26 | Taris Biomedical Llc | Multi-unit drug delivery devices and methods |
| KR20160083061A (ko) * | 2013-11-05 | 2016-07-11 | 타리스 바이오메디컬 엘엘씨 | 삼투 약물 전달 디바이스들, 키트, 및 방법들 |
| US20170246437A1 (en) * | 2014-09-12 | 2017-08-31 | Taris Biomedical Llc | pH-MODULATING DRUG DELIVERY DEVICES AND METHODS |
| CN104998344A (zh) * | 2015-07-27 | 2015-10-28 | 肖雁冰 | 记忆合金硅胶宫内缓释系统 |
-
2018
- 2018-02-01 LT LTEP18705786.4T patent/LT3432970T/lt unknown
- 2018-02-01 CN CN201880013473.1A patent/CN110418658A/zh active Pending
- 2018-02-01 HR HRP20210571TT patent/HRP20210571T1/hr unknown
- 2018-02-01 ES ES18705786T patent/ES2873084T3/es active Active
- 2018-02-01 EP EP18705786.4A patent/EP3432970B1/en active Active
- 2018-02-01 RU RU2019126979A patent/RU2759868C2/ru active
- 2018-02-01 SM SM20210310T patent/SMT202100310T1/it unknown
- 2018-02-01 DK DK18705786.4T patent/DK3432970T3/da active
- 2018-02-01 PL PL18705786T patent/PL3432970T3/pl unknown
- 2018-02-01 RS RS20210609A patent/RS62459B1/sr unknown
- 2018-02-01 JP JP2019541727A patent/JP7366748B2/ja active Active
- 2018-02-01 US US16/302,061 patent/US11020575B2/en active Active
- 2018-02-01 KR KR1020197025677A patent/KR102564771B1/ko active Active
- 2018-02-01 WO PCT/US2018/016463 patent/WO2018144738A1/en not_active Ceased
- 2018-02-01 SG SG11201907033SA patent/SG11201907033SA/en unknown
- 2018-02-01 AU AU2018217094A patent/AU2018217094B2/en active Active
- 2018-02-01 SI SI201830302T patent/SI3432970T1/sl unknown
- 2018-02-01 HU HUE18705786A patent/HUE054587T2/hu unknown
- 2018-02-01 PT PT187057864T patent/PT3432970T/pt unknown
- 2018-02-01 CA CA3052148A patent/CA3052148A1/en active Pending
- 2018-02-01 MX MX2019009080A patent/MX2019009080A/es unknown
-
2019
- 2019-07-31 IL IL268385A patent/IL268385B/en active IP Right Grant
- 2019-07-31 MX MX2024006288A patent/MX2024006288A/es unknown
-
2021
- 2021-05-26 US US17/331,028 patent/US12090292B2/en active Active
- 2021-06-01 CY CY20211100479T patent/CY1124192T1/el unknown
-
2023
- 2023-08-24 AU AU2023219908A patent/AU2023219908B2/en not_active Expired - Fee Related
-
2024
- 2024-09-04 US US18/824,361 patent/US20240424269A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124192T1 (el) | Συσκευες για την in vivo χορηγηση φαρμακων | |
| MX2020005566A (es) | Dispositivos conectores estabilizadores para acceso vascular y metodos de uso de los mismos. | |
| ZA202205265B (en) | Multi-unit drug delivery devices and methods | |
| CO2017013384A2 (es) | Colocación de un shunt intraocular ab externo | |
| CY1120950T1 (el) | Θεραπεια ινωσης | |
| MX2018011742A (es) | Metodo y aparato para suministro de agentes terapeuticos. | |
| MX2019000403A (es) | Cartucho para un dispositivo de captura de insectos y metodos de este. | |
| MX2019008197A (es) | Inhibidores de tgfb1 permisivos del contexto, espicificos de isoformas y uso de los mismos. | |
| EP3496641A4 (en) | DEVICES AND METHOD FOR DELIVERING LIQUID TO TISSUE DURING ABLATION THERAPY | |
| UY37341A (es) | Formulaciones de gamma-hidroxibutirato de liberación modificada con farmacocinética mejorada | |
| MX2017006653A (es) | Metodos para modular los niveles de fármaco en plasma mediante el uso de eritrohidroxibupropión. | |
| MX2019006823A (es) | Tratamiento de una enfermedad del tracto gastrointestinal con inhibidor de interleucina-12/interleucina-23 (il-12/il-23) liberado usando un dispositivo ingerible. | |
| MX2015013683A (es) | Dispositivo de entrenamiento para dispositivos de inyeccion de medicamento y dispositivo de restablecimiento para restablecer tal dispositivo de entrenamiento. | |
| DOP2016000244A (es) | Nanopartículas terapéuticas que comprenden un agente terapéutico, y formas para su elaboración y uso | |
| JOP20200220A1 (ar) | أجهزة لحقن أدوية وطرق استخدامها | |
| WO2015200752A8 (en) | Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems | |
| CL2021001432A1 (es) | Terapia de combinación de radioinmunoconjugados con inhibidores de daños y reparaciones del adn | |
| MX387283B (es) | Tratamiento del cancer con tg02. | |
| MX386870B (es) | Recubrimiento lubricante para dispositivo medico. | |
| ECSP17085443A (es) | Formulación sólida oral que contiene irinotecán y método de preparación de la misma | |
| MX2023001963A (es) | Composiciones farmaceuticas hipertonicas que contienen un agente quimioprotector antiplatino. | |
| ES2836537R1 (es) | Dispositivo medico conector | |
| MX2016015343A (es) | Insercion para cateteres de insercion sobre la aguja. | |
| EP3845639A4 (en) | PROCEDURE FOR EVALUATION OF ANTIINFECTIVES, VACCINES ETC. USING IMMORTALIZED MONOCYTIC CELLS AND INDUCED CELLS | |
| EA201991882A2 (ru) | Комплекс лекарственное средство-устройство, содержащее хинаголид |